Description:

Novolinda solution 30ml is a topical external solution (lotion) used for the treatment of acne vulgaris (especially pustular and cystic acne), acne rosacea, folliculitis, and other skin conditions associated with increased sebum secretion or bacterial involvement. It combines an antibiotic (clindamycin) with an antiprotozoal/antibacterial agent (metronidazole) to reduce inflammation, kill acne-causing bacteria (e.g., Propionibacterium acnes), and control secondary infections or inflammation in acne-prone skin.

Prescription: Prescription-only (Rx) in regulated markets due to the antibiotic components. In Ghana and some African markets, it may be available over-the-counter or through pharmacies, but professional advice is recommended to avoid misuse or resistance.

Therapeutic Category:

Topical anti-acne preparation / Antibacterial + antiprotozoal combination (dermatological anti-infective code equivalent for clindamycin/metronidazole topical).

Active Ingredients/Composition:

• Clindamycin (as clindamycin hydrochloride) 10 mg/ml
• Metronidazole 8 mg/ml Formulated as an external solution (lotion) with excipients (alcohol base or aqueous/alcoholic vehicle, preservatives, etc.; refer to label for full list).

Vitamins: None.

Minerals: None.

Variant: External solution (lotion) in 30ml bottle (standard size for facial application; no major strength variants noted).

Consume Type:

Topical (external solution/lotion; apply to skin only, not ingested or for eyes/mucous membranes).

Directions/Usage: Apply a thin layer to the affected skin areas (clean and dry) 1-2 times daily (morning and/or evening), or as directed by a doctor/pharmacist. Gently massage in; avoid eyes, mouth, and open wounds. Use consistently for 4-8 weeks or as prescribed. Wash hands after application. Not for long-term use without supervision (risk of bacterial resistance or skin irritation).

Common Side Effects:

• Local skin irritation (dryness, peeling, redness, burning/stinging sensation)
• Mild itching or rash
• Rare: Allergic contact dermatitis, increased sensitivity to sunlight (photosensitivity) Most mild and transient; discontinue if severe irritation or allergic reaction occurs.

Package Type:

Plastic bottle of 30 ml (with dropper, nozzle, or flip-top cap for application; often in simple carton or box with label).

Storage Advice: Store at room temperature (below 25-30°C), in a cool, dry place away from direct sunlight and heat. Keep tightly closed. Keep out of reach of children.

Safety Advice:

• External use only; avoid contact with eyes, mouth, or mucous membranes (rinse thoroughly if accidental contact).
• Do not use on broken, infected, or sunburned skin without medical advice.
• Caution in known hypersensitivity to clindamycin, metronidazole, or lincomycin.
• May cause dryness/peeling—use moisturizer if needed; apply sunscreen (photosensitivity risk).
• Not for children under certain age or pregnant/breastfeeding women without doctor advice (systemic absorption minimal but caution).
• If no improvement after 4-6 weeks or worsening (e.g., severe redness, swelling), consult a dermatologist (may indicate resistance or misdiagnosis).
• Report severe irritation or allergic symptoms promptly.

Product Substitutes: Other clindamycin + metronidazole topical solutions/creams in similar markets: Novolinda (same product from CPC1 HN in some regions), Clindacin + Metronidazole generics, or alternatives like Clindamycin lotion alone (Dalacin T), Benzoyl peroxide + clindamycin (Duac), or adapalene + clindamycin (Deriva-CMS). Consult dermatologist for equivalents (e.g., for acne treatment per Ghana guidelines).

Manufacturer/Marketer:

Ha Noi CPC1 Pharmaceutical Joint Stock Company (CPC1 HN; Vietnamese pharmaceutical company producing Novolinda). Marketed/distributed in some regions via local importers/pharmacies (e.g., “Novolinda” branding in Vietnam/exports).

Country of Origin:

Vietnam.